Serum Urate Goals Tied to Lower CV Risk - Takeaways - MDSpire

Serum Urate Goals Tied to Lower CV Risk

  • By

  • Andrea Surnit

  • May 11, 2026

  • 4 min

Share

  • 1

    Achieving serum urate targets with urate-lowering therapy reduces the 5-year risk of major adverse cardiovascular events in gout patients.

  • 2

    In a study of 109,504 adults, those who reached urate levels below 6 mg/dL had a hazard ratio of 0.91 for cardiovascular events.

  • 3

    Patients achieving urate levels below 5 mg/dL showed an even stronger association, with a hazard ratio of 0.77 and a 3 percentage point survival difference.

  • 4

    The study highlights a potential link between gout flares, systemic inflammation, and cardiovascular risk, rather than urate lowering alone.

  • 5

    Despite adjustments, residual confounding may affect results, and fewer than one-third of patients achieved target urate levels within the first year.

Original Source(s)

Related Content